Food allergy indication strategy report covering epidemiology, FCER1A biology, active trials, competition and deal signals using PatSnap MCP evidence.

Chronic inducible urticaria indication strategy report covering epidemiology, FCER1A biology, active trials, competition and deal signals using PatSnap MCP evidence.

Chronic hand eczema indication strategy report covering epidemiology, IL-4Rα biology, active trials, competition and deal signals using PatSnap MCP evidence.

Prurigo nodularis indication strategy report covering epidemiology, IL-31RA biology, active trials, competition and deal signals using PatSnap MCP evidence.

Sarcoidosis indication strategy report covering epidemiology, TNF biology, active trials, competition and deal signals using PatSnap MCP evidence.

IgG4-related disease indication strategy report covering epidemiology, CD19 biology, active trials, competition and deal signals using PatSnap MCP evidence.

Takayasu arteritis indication strategy report covering epidemiology, IL-6R biology, active trials, competition and deal signals using PatSnap MCP evidence.

Antiphospholipid syndrome indication strategy report covering epidemiology, C5 biology, active trials, competition and deal signals using PatSnap MCP evidence.

Relapsing polychondritis indication strategy report covering epidemiology, IL-6R biology, active trials, competition and deal signals using PatSnap MCP evidence.

Behcet disease indication strategy report covering epidemiology, TNF biology, active trials, competition and deal signals using PatSnap MCP evidence.

VEXAS syndrome indication strategy report covering epidemiology, UBA1 biology, active trials, competition and deal signals using PatSnap MCP evidence.

Cryopyrin-associated periodic syndromes indication strategy report covering epidemiology, NLRP3 biology, active trials, competition and deal signals using...